{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:12:16Z","timestamp":1788509536378,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum. Genet."],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gene-based therapies are being developed for retinal diseases, including\n                    <jats:italic>RS1-<\/jats:italic>\n                    related X-linked retinoschisis. Therefore it is essential to determine which variants are pathogenic and which are benign when enrolling patients. The Clinical Genome Resource (ClinGen) X-Linked Inherited Retinal Diseases (XLRD) Variant Curation Expert Panel (VCEP) brings together clinician scientists, molecular biologists, and geneticists to apply their expertise and review the clinical, genetic, population, and functional evidence for variants. American College of Medical Genetics (ACMG) guidelines have been modified for\n                    <jats:italic>RS1<\/jats:italic>\n                    to develop a highly systematic and conservative framework for evaluating variants. The curation process involves applying 28 different codes, each with 4 strength levels (very strong, strong, moderate, supporting) across different domains of phenotype, population data, computational assessment, functional impact, and segregation. With\n                    <jats:italic>RS1-<\/jats:italic>\n                    specific rules, a total of 54 pilot variants were tested. These included 47 variants in ClinVar. Of these 21 variants were re-classified: 2 likely pathogenic variants and one likely benign were changed to variants of uncertain significance and 4 previously unclassified variants were changed to pathogenic, likely pathogenic and likely benign. Other changes resolved conflicts or multiple classifications.\n                  <\/jats:p>","DOI":"10.1007\/s00439-026-02871-0","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:15:34Z","timestamp":1788506134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of RS1-specific ACMG\/AMP variant classification criteria with pilot variant curation"],"prefix":"10.1007","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8834-6641","authenticated-orcid":false,"given":"Sarah","family":"Hull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. S.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ayyagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Haer-Wigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. B.","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M. J.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"K\u00e4mpj\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Sieving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. C.","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"2871_CR40","doi-asserted-by":"crossref","unstructured":"Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, Harrison SM; ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI). Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum Mutat. 2018 Nov;39(11):1517-1524. doi: 10.1002\/humu.23626 https:\/\/www","DOI":"10.1002\/humu.23626"},{"key":"2871_CR1","doi-asserted-by":"publisher","unstructured":"Bender C, Woo EG, Guan B, Ullah E, Feng E, Turriff A, Tumminia SJ, Sieving PA, Cukras CA, Hufnagel RB (2022) Predominant Founder Effect among Recurrent Pathogenic Variants for an X-Linked Disorder. Genes (Basel) 13(4). https:\/\/doi.org\/10.3390\/genes13040675. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35456481","DOI":"10.3390\/genes13040675"},{"issue":"12","key":"2871_CR3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/gim.2018.42","volume":"20","author":"LG Biesecker","year":"2018","unstructured":"Biesecker LG, Harrison SM, ClinGen Sequence Variant Interpretation Working Group (2018) The ACMG\/AMP reputable source criteria for the interpretation of sequence variants. Genet Med 20(12):1687\u20131688. https:\/\/doi.org\/10.1038\/gim.2018.42. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29543229","journal-title":"Genet Med"},{"issue":"1","key":"2871_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajhg.2023.11.009","volume":"111","author":"LG Biesecker","year":"2024","unstructured":"Biesecker LG, Byrne AB, Harrison SM, Pesaran T, Schaffer AA, Shirts BH, Tavtigian SV, Rehm HL, Group ClinGen Sequence Variant Interpretation Working (2024) ClinGen guidance for use of the PP1\/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification. Am J Hum Genet 111(1):24\u201338. https:\/\/doi.org\/10.1016\/j.ajhg.2023.11.009. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38103548","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2871_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/hmg\/ddae028","volume":"33","author":"DC Brock","year":"2024","unstructured":"Brock DC, Wang M, Hussain HMJ, Rauch DE, Marra M, Pennesi ME, Yang P, Everett L, Ajlan RS, Colbert J, Porto FBO, Matynia A, Gorin MB, Koenekoop RK, Lopez I, Sui R, Zou G, Li Y, Chen R (2024) Comparative analysis of in-silico tools in identifying pathogenic variants in dominant inherited retinal diseases. Hum Mol Genet 33(11):945\u2013957. https:\/\/doi.org\/10.1093\/hmg\/ddae028. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38453143","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2871_CR5","doi-asserted-by":"publisher","first-page":"e0147653","DOI":"10.1371\/journal.pone.0147653","volume":"11","author":"M Bush","year":"2016","unstructured":"Bush M, Setiaputra D, Yip CK, Molday RS (2016) Cog-Wheel Octameric Structure of RS1, the Discoidin Domain Containing Retinal Protein Associated with X-Linked Retinoschisis. PLoS ONE 11(1):e0147653. https:\/\/doi.org\/10.1371\/journal.pone.0147653. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26812435","journal-title":"PLoS ONE"},{"key":"2871_CR6","doi-asserted-by":"publisher","unstructured":"De Silva SR, Arno G, Robson AG, Fakin A, Pontikos N, Mohamed MD, Bird AC, Moore AT, Michaelides M, Webster AR, Mahroo OA (2020) The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies. Prog Retin Eye Res 100898. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100898. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32860923","DOI":"10.1016\/j.preteyeres.2020.100898"},{"issue":"6","key":"2871_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PE (2016) HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Hum Mutat 37(6):564\u2013569. https:\/\/doi.org\/10.1002\/humu.22981. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26931183","journal-title":"Hum Mutat"},{"issue":"6","key":"2871_CR8","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1167\/iovs.06-1465","volume":"48","author":"FM Dyka","year":"2007","unstructured":"Dyka FM, Molday RS (2007) Coexpression and interaction of wild-type and missense RS1 mutants associated with X-linked retinoschisis: its relevance to gene therapy. Invest Ophthalmol Vis Sci 48(6):2491\u20132497. https:\/\/doi.org\/10.1167\/iovs.06-1465. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17525175","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"2871_CR9","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/bjophthalmol-2016-310110","volume":"101","author":"AT Fahim","year":"2017","unstructured":"Fahim AT, Ali N, Blachley T, Michaelides M (2017) Peripheral fundus findings in X-linked retinoschisis. Br J Ophthalmol 101(11):1555\u20131559. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-310110. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28348004","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"2871_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/bjo.79.7.697","volume":"79","author":"ND George","year":"1995","unstructured":"George ND, Yates JR, Moore AT (1995) X linked retinoschisis. Br J Ophthalmol 79(7):697\u2013702. https:\/\/doi.org\/10.1136\/bjo.79.7.697. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7662639","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2871_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ophtha.2021.11.019","volume":"129","author":"M Georgiou","year":"2022","unstructured":"Georgiou M, Finocchio L, Fujinami K, Fujinami-Yokokawa Y, Virgili G, Mahroo OA, Webster AR, Michaelides M (2022) X-Linked Retinoschisis: Deep Phenotyping and Genetic Characterization. Ophthalmology 129(5):542\u2013551. https:\/\/doi.org\/10.1016\/j.ophtha.2021.11.019. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34822951","journal-title":"Ophthalmology"},{"issue":"1","key":"2871_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/BJ20091179","volume":"425","author":"LJ Gleghorn","year":"2009","unstructured":"Gleghorn LJ, Trump D, Bulleid NJ (2009) Wild-type and missense mutants of retinoschisin co-assemble resulting in either intracellular retention or incorrect assembly of the functionally active octamer. Biochem J 425(1):275\u2013283. https:\/\/doi.org\/10.1042\/BJ20091179. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19849666","journal-title":"Biochem J"},{"issue":"4154","key":"2871_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.185.4154.862","volume":"185","author":"R Grantham","year":"1974","unstructured":"Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185(4154):862\u2013864. https:\/\/doi.org\/10.1126\/science.185.4154.862. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4843792","journal-title":"Science"},{"issue":"12","key":"2871_CR14","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/hmg\/9.12.1873","volume":"9","author":"C Grayson","year":"2000","unstructured":"Grayson C, Reid SN, Ellis JA, Rutherford A, Sowden JC, Yates JR, Farber DB, Trump D (2000) Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells. Hum Mol Genet 9(12):1873\u20131879. https:\/\/doi.org\/10.1093\/hmg\/9.12.1873. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10915776","journal-title":"Hum Mol Genet"},{"key":"2871_CR15","doi-asserted-by":"publisher","unstructured":"Hahn LC, van Schooneveld MJ, Wesseling NL, Florijn RJ, Ten Brink JB, Lissenberg-Witte BI, Strubbe I, Meester-Smoor MA, Thiadens AA, Diederen RM, van Cauwenbergh C, de Zaeytijd J, Walraedt S, de Baere E, Klaver CCW, Ossewaarde-van Norel J, van den Born LI, Hoyng CB, van Genderen MM, Sieving PA, Leroy BP, Bergen AA and Boon CJF (2022) X-Linked Retinoschisis: Novel Clinical Observations and Genetic Spectrum in 340 Patients. Ophthalmology 129 (2): 191\u2013202. https:\/\/doi.org\/10.1016\/j.ophtha.2021.09.021. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34624300","DOI":"10.1016\/j.ophtha.2021.09.021"},{"key":"2871_CR16","doi-asserted-by":"publisher","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D, Cannon-Albright LA, Teerlink CC, Stanford JL, Isaacs WB, Xu J, Cooney KA, Lange EM, Schleutker J, Carpten JD, Powell IJ, Cussenot O, Cancel-Tassin G, Giles GG, MacInnis RJ, Maier C, Hsieh CL, Wiklund F, Catalona WJ, Foulkes WD, Mandal D, Eeles RA, Kote-Jarai Z, Bustamante CD, Schaid DJ, Hastie T, Ostrander EA, Bailey-Wilson JE, Radivojac P, Thibodeau SN A. S. Whittemore, and Sieh W (2016) REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet 99 (4): 877\u2013885. https:\/\/doi.org\/10.1016\/j.ajhg.2016.08.016. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27666373","DOI":"10.1016\/j.ajhg.2016.08.016"},{"issue":"3","key":"2871_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, Kosmicki JA, Arbelaez J, Cui W, Schwartz GB, Chow ED, Kanterakis E, Gao H, Kia A, Batzoglou S, Sanders SJ, Farh KK (2019) Predicting Splicing Prim Seq Deep Learn Cell 176(3):535\u2013548e24. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30661751","journal-title":"Predicting Splicing Prim Seq Deep Learn Cell"},{"issue":"7809","key":"2871_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O\u2019Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, Neale BM, Daly MJ, MacArthur DG (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809):434\u2013443. https:\/\/doi.org\/10.1038\/s41586-020-2308-7. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32461654","journal-title":"Nature"},{"key":"2871_CR19","first-page":"833","volume":"15","author":"SY Kim","year":"2009","unstructured":"Kim SY, Ko HS, Yu YS, Hwang JM, Lee JJ, Kim JY, Seong MW, Park KH, Park SS (2009) Molecular genetic characteristics of X-linked retinoschisis in Koreans. Mol Vis 15:833\u2013843. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19390641","journal-title":"Mol Vis"},{"key":"2871_CR20","doi-asserted-by":"publisher","unstructured":"Kirkby J, Halford S, Shanks M, Moore A, Gait A, Jenkins L, Clouston P, Patel CK, Downes SM (2023) A Carrier Female Manifesting an Unusual X-Linked Retinoschisis Phenotype Associated with the Pathogenic Variant c.266delA, p.(Tyr89LeufsTer37) in RS1, and Skewed X-Inactivation. Genes (Basel) 614. https:\/\/doi.org\/10.3390\/genes14061193. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37372373","DOI":"10.3390\/genes14061193"},{"issue":"Database issue","key":"2871_CR21","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR (2014) ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42(Database issue):D980\u2013D985. https:\/\/doi.org\/10.1093\/nar\/gkt1113. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24234437","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2871_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41436-019-0722-8","volume":"22","author":"E Lenassi","year":"2020","unstructured":"Lenassi E, Clayton-Smith J, Douzgou S, Ramsden SC, Ingram S, Hall G, Hardcastle CL, Fletcher TA, Taylor RL, Ellingford JM, Newman WD, Fenerty C, Sharma V, Lloyd IC, Biswas S, Ashworth JL, Black GC, Sergouniotis PI (2020) Clinical utility of genetic testing in 201 preschool children with inherited eye disorders. Genet Med 22(4):745\u2013751. https:\/\/doi.org\/10.1038\/s41436-019-0722-8. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31848469","journal-title":"Genet Med"},{"issue":"18","key":"2871_CR23","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1093\/hmg\/ddz122","volume":"28","author":"Y Liu","year":"2019","unstructured":"Liu Y, Kinoshita J, Ivanova E, Sun D, Li H, Liao T, Cao J, Bell BA, Wang JM, Tang Y, Brydges S, Peachey NS, Sagdullaev BT, Romano C (2019) Mouse models of X-linked juvenile retinoschisis have an early onset phenotype, the severity of which varies with genotype. Hum Mol Genet 28(18):3072\u20133090. https:\/\/doi.org\/10.1093\/hmg\/ddz122. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31174210","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2871_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.preteyeres.2011.12.002","volume":"31","author":"RS Molday","year":"2012","unstructured":"Molday RS, Kellner U, Weber BH (2012) X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms. Prog Retin Eye Res 31(3):195\u2013212. https:\/\/doi.org\/10.1016\/j.preteyeres.2011.12.002. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22245536","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"2871_CR25","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver V, Byrne AB, Feng BJ, Pagel KA, Mooney SD, Karchin R, O\u2019Donnell-Luria A, Harrison SM, Tavtigian SV, Greenblatt MS, Biesecker LG, Radivojac P, Brenner SE, Group ClinGen Sequence Variant Interpretation Working (2022) Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet 109(12):2163\u20132177. https:\/\/doi.org\/10.1016\/j.ajhg.2022.10.013. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36413997","journal-title":"Am J Hum Genet"},{"key":"2871_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.exer.2018.07.021","volume":"177","author":"K Pl\u00f6ssl","year":"2018","unstructured":"Pl\u00f6ssl K, Schmid V, Straub K, Schmid C, Ammon M, Merkl R, Weber BHF, Friedrich U (2018) Pathomechanism of mutated and secreted retinoschisin in X-linked juvenile retinoschisis. Exp Eye Res 177:23\u201334. https:\/\/doi.org\/10.1016\/j.exer.2018.07.021. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30040949","journal-title":"Exp Eye Res"},{"issue":"23","key":"2871_CR27","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, Ledbetter DH, Maglott DR, Martin CL, Nussbaum RL, Plon SE, Ramos EM, Sherry ST, Watson MS (2015) ClinGen\u2013the Clinical Genome Resource. N Engl J Med 372(23):2235\u20132242. https:\/\/doi.org\/10.1056\/NEJMsr1406261","journal-title":"N Engl J Med"},{"issue":"5","key":"2871_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013423. https:\/\/doi.org\/10.1038\/gim.2015.30. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25741868","journal-title":"Genet Med"},{"issue":"2","key":"2871_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ng1097-164","volume":"17","author":"CG Sauer","year":"1997","unstructured":"Sauer CG, Gehrig A, Warneke-Wittstock R, Marquardt A, Ewing CC, Gibson A, Lorenz B, Jurklies B, Weber BH (1997) Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet 17(2):164\u2013170. https:\/\/doi.org\/10.1038\/ng1097-164. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9326935","journal-title":"Nat Genet"},{"issue":"10","key":"2871_CR30","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/humu.24088","volume":"41","author":"SV Tavtigian","year":"2020","unstructured":"Tavtigian SV, Harrison SM, Boucher KM, Biesecker LG (2020) Fitting a naturally scaled point system to the ACMG\/AMP variant classification guidelines. Hum Mutat 41(10):1734\u20131737. https:\/\/doi.org\/10.1002\/humu.24088. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32720330","journal-title":"Hum Mutat"},{"issue":"7","key":"2871_CR31","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/hmg\/7.7.1185","volume":"7","author":"The Retinoschisis Consortium","year":"1998","unstructured":"The Retinoschisis Consortium (1998) Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis. The Retinoschisis Consortium. Hum Mol Genet 7(7):1185\u20131192. https:\/\/doi.org\/10.1093\/hmg\/7.7.1185. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9618178","journal-title":"Hum Mol Genet"},{"issue":"19","key":"2871_CR32","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1073\/pnas.1519048113","volume":"113","author":"G Tolun","year":"2016","unstructured":"Tolun G, Vijayasarathy C, Huang R, Zeng Y, Li Y, Steven AC, Sieving PA, Heymann JB (2016) Paired octamer rings of retinoschisin suggest a junctional model for cell-cell adhesion in the retina. Proc Natl Acad Sci U S A 113(19):5287\u20135292. https:\/\/doi.org\/10.1073\/pnas.1519048113. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27114531","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2871_CR33","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"110","author":"LC Walker","year":"2023","unstructured":"Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, Canson DM, Bis-Brewer D, Cass A, Tchourbanov A, Zimmermann H, Byrne AB, Pesaran T, Karam R, Harrison SM, Spurdle AB, Group ClinGen Sequence Variant Interpretation Working (2023) Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet 110(7):1046\u20131067. https:\/\/doi.org\/10.1016\/j.ajhg.2023.06.002. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37352859","journal-title":"Am J Hum Genet"},{"issue":"24","key":"2871_CR34","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1093\/hmg\/11.24.3097","volume":"11","author":"T Wang","year":"2002","unstructured":"Wang T, Waters CT, Rothman AM, Jakins TJ, Romisch K, Trump D (2002) Intracellular retention of mutant retinoschisin is the pathological mechanism underlying X-linked retinoschisis. Hum Mol Genet 11(24):3097\u20133105. https:\/\/doi.org\/10.1093\/hmg\/11.24.3097. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12417531","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2871_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/bjo.2005.078048","volume":"90","author":"T Wang","year":"2006","unstructured":"Wang T, Zhou A, Waters CT, O\u2019Connor E, Read RJ, Trump D (2006) Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation. Br J Ophthalmol 90(1):81\u201386. https:\/\/doi.org\/10.1136\/bjo.2005.078048. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16361673","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"2871_CR36","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2017.26","volume":"19","author":"N Whiffin","year":"2017","unstructured":"Whiffin N, Minikel E, Walsh R, O\u2019Donnell-Luria AH, Karczewski K, Ing AY, Barton PJR, Funke B, Cook SA, MacArthur D, Ware JS (2017) Using high-resolution variant frequencies to empower clinical genome interpretation. Genet Med 19(10):1151\u20131158. https:\/\/doi.org\/10.1038\/gim.2017.26. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28518168","journal-title":"Genet Med"},{"issue":"30","key":"2871_CR37","doi-asserted-by":"publisher","first-page":"28139","DOI":"10.1074\/jbc.M302464200","volume":"278","author":"WW Wu","year":"2003","unstructured":"Wu WW, Molday RS (2003) Defective discoidin domain structure, subunit assembly, and endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis. J Biol Chem 278(30):28139\u201328146. https:\/\/doi.org\/10.1074\/jbc.M302464200. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12746437","journal-title":"J Biol Chem"},{"issue":"11","key":"2871_CR38","doi-asserted-by":"publisher","first-page":"10721","DOI":"10.1074\/jbc.M413117200","volume":"280","author":"WW Wu","year":"2005","unstructured":"Wu WW, Wong JP, Kast J, Molday RS (2005) RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer. J Biol Chem 280(11):10721\u201310730. https:\/\/doi.org\/10.1074\/jbc.M413117200. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15644328","journal-title":"J Biol Chem"},{"issue":"3","key":"2871_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/bjophthalmol-2021-319668","volume":"107","author":"S Xiao","year":"2023","unstructured":"Xiao S, Sun W, Xiao X, Li S, Luo H, Jia X, Ouyang J, Li X, Wang Y, Jiang Y, Wang P, Zhang Q (2023) Clinical and genetic features of retinoschisis in 120 families with. Br J Ophthalmol 107(3):367\u2013372. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319668. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34645606","journal-title":"Br J Ophthalmol"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-026-02871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00439-026-02871-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-026-02871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:15:35Z","timestamp":1788506135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00439-026-02871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2871"],"URL":"https:\/\/doi.org\/10.1007\/s00439-026-02871-0","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GW is employed by Labcorp, KL and WH receive funding from Janssen. SH\/MM\/WH\/LSS\/RA\/MDB\/LH-W\/RBH\/HMJH\/KK\/PAS\/MW\/CZ\/RAL\/RC\/KCW declare no conflicts.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"75"}}